Press Release MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Aug 13
Press Release AGAPE-1 Technology Enters Fundraising Agreement with Castle Placement LLC to Raise Up to $8 Million Aug 13
Press Release U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse Aug 13
Press Release Health Optimization & Longevity Arrives in Boulder: Next Health Celebrates Grand Opening with Live Podcast Recording Featuring Dr. Darshan Shah and Ben Greenfield Aug 13